While, we believe that chronic IL-6 expression may be responsible for STAT3 and NFκB downregulation in tumor associated inflammatory cells; its systemic effect may be stimulatory, due to lower concentration in the body compared to the intratumoral concentration. The gene discussed is STAT3; the disease is neoplasm.